Notably, gain-of-function mutations within Scn9a, the gene encoding NaV1.7, underlie distinct human pain syndromes such as inherited erythromelalgia and paroxysmal extreme pain disorder (8). The gene discussed is SCN9A; the disease is paroxysmal extreme pain disorder.